Upgrade to SI Premium - Free Trial

Citi Adds Nektar Therapeutics (NKTR) to 30-Day Upside Catalyst Watch List

April 7, 2026 8:36 AM
Citi analyst Samantha Semenkow reiterated a Buy rating and $123.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Trader Talk